Zimbabwe has declined a significant American health deal valued at $367m (272 million pounds) spanning five years over the United States' request for confidential data.
This rejection was revealed after a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesperson has since clarified that the United States was demanding access to health data for research and profit but was unwilling to share the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for further talks to reach a deal agreeable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Implications
This rejection comes after a comparable situation in Kenya, where a high court blocked a related health funding agreement following concerns were filed about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and accountability.
Based on statements, Sixteen African countries have to date agreed to these new agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Effectively, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our people if a future health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one deals were disrupting systems already set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage further discussions with our US partners on how future co-operation could be designed in a manner that respects the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but suggested that talks need to persist given that much of the country's Aids initiatives were funded by external financing.
"In cases where technical issues arise, such as those involving information security or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," it said.
This impasse underscores the ongoing challenges between accepting vital international aid and protecting national sovereignty in an increasingly interconnected world.